ID20463A - Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea - Google Patents
Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan ureaInfo
- Publication number
- ID20463A ID20463A IDP980873A ID980873A ID20463A ID 20463 A ID20463 A ID 20463A ID P980873 A IDP980873 A ID P980873A ID 980873 A ID980873 A ID 980873A ID 20463 A ID20463 A ID 20463A
- Authority
- ID
- Indonesia
- Prior art keywords
- aminofenyl
- alkilsulfonamida
- penil
- urea decreases
- urea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5047997P | 1997-06-23 | 1997-06-23 | |
US7597898P | 1998-02-25 | 1998-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID20463A true ID20463A (id) | 1998-12-24 |
Family
ID=26728313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP980873A ID20463A (id) | 1997-06-23 | 1998-06-12 | Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea |
Country Status (31)
Country | Link |
---|---|
US (2) | US5952362A (tr) |
EP (1) | EP0887346B1 (tr) |
JP (1) | JP2977536B2 (tr) |
KR (1) | KR100608501B1 (tr) |
CN (3) | CN1262547C (tr) |
AR (1) | AR013005A1 (tr) |
AT (1) | ATE380793T1 (tr) |
AU (1) | AU713068C (tr) |
BR (1) | BR9802201B1 (tr) |
CA (3) | CA2240136C (tr) |
CO (1) | CO4940479A1 (tr) |
CZ (1) | CZ197498A3 (tr) |
DE (1) | DE69838829T2 (tr) |
ES (1) | ES2297870T3 (tr) |
HK (1) | HK1016985A1 (tr) |
HR (1) | HRP980353A2 (tr) |
HU (1) | HUP9801357A3 (tr) |
ID (1) | ID20463A (tr) |
IL (2) | IL124839A (tr) |
MA (1) | MA26515A1 (tr) |
MY (1) | MY128048A (tr) |
NO (1) | NO310868B1 (tr) |
NZ (1) | NZ330506A (tr) |
PE (1) | PE85999A1 (tr) |
PL (1) | PL198053B1 (tr) |
RU (1) | RU2218335C2 (tr) |
SG (1) | SG72827A1 (tr) |
TR (1) | TR199801197A2 (tr) |
TW (1) | TW517049B (tr) |
UY (1) | UY25057A1 (tr) |
YU (1) | YU26498A (tr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407132B1 (en) * | 1997-07-25 | 2002-06-18 | James Black Foundation Limited | Substituted imidazole derivatives and their use as histamine H3 receptor ligands |
DE19824175A1 (de) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino-azol-Verbindungen |
US6503935B1 (en) * | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
US20030073850A1 (en) * | 1998-08-07 | 2003-04-17 | Altenbach Robert J. | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use |
US6395758B1 (en) * | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
GB9910110D0 (en) * | 1999-04-30 | 1999-06-30 | Glaxo Group Ltd | Chemical compounds |
US6323231B1 (en) | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
US20020183357A1 (en) * | 2000-02-17 | 2002-12-05 | Brioni Jorge D. | Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence |
AU2001259536A1 (en) * | 2000-05-10 | 2001-11-20 | The Cleveland Clinic Foundation | Model systems for neurodegenerative and cardiovascular disorders |
AU2001286557A1 (en) * | 2000-08-23 | 2002-03-04 | Merck Frosst Canada And Co. | Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists |
EP1341529A2 (en) * | 2000-11-10 | 2003-09-10 | F. Hoffman-la Roche AG | Hydrolytically unstable compositions |
DE10106214A1 (de) * | 2001-02-10 | 2002-08-14 | Boehringer Ingelheim Pharma | Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz |
US20020169193A1 (en) * | 2001-02-10 | 2002-11-14 | Pascale Pouzet | Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence |
US20040170689A1 (en) * | 2001-11-09 | 2004-09-02 | Odink Debra Alida | Stabilized formulations comprising hydrolytically unstable compositions |
US6703409B2 (en) | 2002-01-31 | 2004-03-09 | Boehringer Ingelheim Pharma Gmbh & Co Kg | 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug |
EP1333028A1 (en) * | 2002-01-31 | 2003-08-06 | Boehringer Ingelheim Pharma GmbH & Co.KG | 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
RU2337909C2 (ru) * | 2002-02-01 | 2008-11-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора |
CA2483345C (en) * | 2002-04-23 | 2010-12-21 | F. Hoffmann-La Roche Ag | Imidazolinylmethyl aralkylsulfonamides |
ATE406363T1 (de) * | 2003-05-09 | 2008-09-15 | Hoffmann La Roche | Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten |
US20060258986A1 (en) * | 2005-02-11 | 2006-11-16 | Hunter Ian W | Controlled needle-free transport |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
GB0519294D0 (en) * | 2005-09-21 | 2005-11-02 | Karobio Ab | Compounds |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
WO2009012283A1 (en) | 2007-07-17 | 2009-01-22 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
KR20100096262A (ko) * | 2008-02-04 | 2010-09-01 | 에프. 호프만-라 로슈 아게 | 신규한 이미다졸리닐메틸 아릴 설폰아미드 |
AU2009211503A1 (en) * | 2008-02-04 | 2009-08-13 | F. Hoffmann-La Roche Ag | Novel imidazolinylmethyl aryl sulfonamides |
JP4168086B1 (ja) * | 2008-04-16 | 2008-10-22 | 国立大学法人福井大学 | イミダゾリン誘導体 |
MX349923B (es) | 2009-04-03 | 2017-08-21 | Hoffmann La Roche | Composiciones del ácido propano-1-sulfónico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil]-amida y el uso de las mismas. |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
ES2633317T3 (es) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compuestos y métodos para la modulación de quinasas, e indicaciones para ello |
PT2672967T (pt) | 2011-02-07 | 2018-12-07 | Plexxikon Inc | Compostos e métodos de modulação da quinase e suas indicações |
AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
TW201603707A (zh) * | 2014-06-24 | 2016-02-01 | 陶氏農業科學公司 | 具有特定殺蟲效用之分子及與其相關之中間物、組成物和製程 |
CN106543077B (zh) * | 2016-10-27 | 2019-08-23 | 西安交通大学 | N,n’-双取代芳基硫脲衍生物及其合成方法和应用 |
CN106905181B (zh) * | 2017-04-14 | 2018-10-09 | 上海海洋大学 | 一种立达霉代谢产物16的合成方法 |
CN108863818A (zh) * | 2018-06-28 | 2018-11-23 | 江苏新瑞药业有限公司 | 一种对氨基间甲酚的合成方法 |
CN109651289B (zh) * | 2018-12-18 | 2022-08-09 | 五邑大学 | 一种3-噻唑啉化合物及其合成方法和应用 |
EP3958851A4 (en) * | 2019-04-23 | 2022-12-28 | The Cleveland Clinic Foundation | ALPHA IA ADRENEGIC RECEPTOR ALLOSTERIC ACTIVATORS |
CA3153305A1 (en) * | 2019-10-25 | 2021-04-29 | Anthony P. FORD | Methods for treating neurological disorders with ?1a-ar partial agonists |
EP4204404A1 (en) * | 2020-08-27 | 2023-07-05 | Curasen Therapeutics, Inc. | Alpha1a-adrenergic receptor agonists and methods of use |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE135016C (tr) * | ||||
US2663732A (en) * | 1950-04-29 | 1953-12-22 | Eastman Kodak Co | (alkysulfonamido) arylhydrazines |
DE1151331B (de) * | 1957-11-15 | 1963-07-11 | Bayer Ag | Verfahren zur Herstellung metallhaltiger Monoazofarbstoffe |
AT241435B (de) * | 1963-06-11 | 1965-07-26 | Chemie Linz Ag | Verfahren zur Herstellung von neuen Phenylalkanolaminderivaten und deren Salzen |
ES323985A1 (es) * | 1966-02-26 | 1966-12-16 | Blade Pique Juan | Procedimiento para la obtenciën de derivados del imidazol |
CH641640A5 (de) * | 1976-12-20 | 1984-03-15 | Wellcome Found | Verfahren zur herstellung neuer imidazoline, pestizide zubereitungen, welche die imidazoline enthalten, und deren verwendung zum bekaempfen von schaedlingen. |
GB1592649A (en) * | 1976-12-20 | 1981-07-08 | Wellcome Found | Imidazoline derivatives and their use as pesticides |
CH632268A5 (de) * | 1977-01-14 | 1982-09-30 | Sandoz Ag | Verfahren zur herstellung von neuen heterocyclylaminoderivaten. |
US4238497A (en) * | 1977-10-26 | 1980-12-09 | Burroughs Wellcome Co. | Imidazoline derivatives, salts thereof and their use as pesticides |
CA1138451A (en) * | 1979-04-03 | 1982-12-28 | Ikuo Ueda | 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same |
US4343808A (en) * | 1979-10-25 | 1982-08-10 | The Dow Chemical Company | Method of inhibiting sickling of sickle erythrocytes |
DE3168754D1 (en) * | 1980-07-09 | 1985-03-21 | Beecham Group Plc | Clonidine derivatives useful in the treatment of diarrhoea |
FR2521140A1 (fr) * | 1982-02-05 | 1983-08-12 | Synthelabo | Derives d'imidazolidine, leur preparation et leur application en therapeutique |
FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
HU192986B (en) * | 1984-05-23 | 1987-08-28 | Egyt Gyogyszervegyeszeti Gyar | Process for production of imidasodiline derivatives |
US4665095A (en) * | 1985-12-11 | 1987-05-12 | Abbott Laboratories | Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion |
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
US5360822A (en) * | 1990-02-07 | 1994-11-01 | Nippon Shinyaku Co. Ltd. | Sulfonanilide derivatives and medicine |
US5389650A (en) * | 1991-09-30 | 1995-02-14 | Merck Frosst Canada, Inc. | (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
AU3488693A (en) * | 1992-02-13 | 1993-09-03 | Merck Frosst Canada Inc. | (Azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis |
WO1994008040A1 (en) * | 1992-09-25 | 1994-04-14 | Synaptic Pharmaceutical Corporation | Dna encoding human alpha 1 adrenergic receptors and uses thereof |
DE663014T1 (de) * | 1992-09-25 | 1996-10-10 | Synaptic Pharmaceutical Corp., Paramus, N.J. | Für menschliche alpha-1-adrenerge rezeptoren kodierende dns und ihre verwendung. |
US5403847A (en) * | 1992-11-13 | 1995-04-04 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperlasia |
US5578611A (en) * | 1992-11-13 | 1996-11-26 | Synaptic Pharmaceutical Corporation | Use of α-1C specific compounds to treat benign prostatic hyperplasia |
WO1995014007A1 (en) * | 1993-11-15 | 1995-05-26 | Schering Corporation | Phenyl-alkyl imidazoles as h3-receptor antagonists |
US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
US5576437A (en) * | 1993-12-17 | 1996-11-19 | The Procter & Gamble Company | 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
AU704972B2 (en) * | 1994-08-04 | 1999-05-13 | H. Lundbeck A/S | Novel benzimidazole derivatives |
WO1996017612A1 (en) * | 1994-12-08 | 1996-06-13 | Knoll Aktiengesellschaft | Use of substituted phenylamidine and phenylguanidine compounds for the treatment of cerebral and cardiac ischaemia, convulsion and sickle cell anaemia |
US5597823A (en) * | 1995-01-27 | 1997-01-28 | Abbott Laboratories | Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
US5610174A (en) * | 1995-06-02 | 1997-03-11 | Synaptic Pharmaceutical Corporation | Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence |
WO1996038143A1 (en) * | 1995-06-02 | 1996-12-05 | Synaptic Pharmaceutical Corporation | The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
US5677321A (en) * | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
AU727972B2 (en) * | 1996-05-16 | 2001-01-04 | H. Lundbeck A/S | Dihydropyrimidines and uses thereof |
-
1998
- 1998-05-18 SG SG1998001348A patent/SG72827A1/en unknown
- 1998-05-25 NZ NZ330506A patent/NZ330506A/xx unknown
- 1998-06-03 US US09/089,779 patent/US5952362A/en not_active Expired - Lifetime
- 1998-06-05 CA CA002240136A patent/CA2240136C/en not_active Expired - Fee Related
- 1998-06-05 CA CA002418778A patent/CA2418778C/en not_active Expired - Fee Related
- 1998-06-05 CA CA002430623A patent/CA2430623A1/en not_active Abandoned
- 1998-06-10 IL IL12483998A patent/IL124839A/en not_active IP Right Cessation
- 1998-06-12 ID IDP980873A patent/ID20463A/id unknown
- 1998-06-12 ES ES98110822T patent/ES2297870T3/es not_active Expired - Lifetime
- 1998-06-12 EP EP98110822A patent/EP0887346B1/en not_active Expired - Lifetime
- 1998-06-12 AT AT98110822T patent/ATE380793T1/de active
- 1998-06-12 DE DE69838829T patent/DE69838829T2/de not_active Expired - Lifetime
- 1998-06-17 HU HU9801357A patent/HUP9801357A3/hu unknown
- 1998-06-18 YU YU26498A patent/YU26498A/sh unknown
- 1998-06-19 MY MYPI98002785A patent/MY128048A/en unknown
- 1998-06-19 JP JP10172403A patent/JP2977536B2/ja not_active Expired - Fee Related
- 1998-06-19 AR ARP980102929A patent/AR013005A1/es not_active Application Discontinuation
- 1998-06-19 NO NO19982884A patent/NO310868B1/no not_active IP Right Cessation
- 1998-06-19 CO CO98035130A patent/CO4940479A1/es unknown
- 1998-06-19 UY UY25057A patent/UY25057A1/es unknown
- 1998-06-22 PE PE1998000547A patent/PE85999A1/es not_active Application Discontinuation
- 1998-06-22 RU RU98111769/04A patent/RU2218335C2/ru not_active IP Right Cessation
- 1998-06-22 KR KR1019980023417A patent/KR100608501B1/ko not_active IP Right Cessation
- 1998-06-22 MA MA25130A patent/MA26515A1/fr unknown
- 1998-06-22 CN CNB031386059A patent/CN1262547C/zh not_active Expired - Fee Related
- 1998-06-22 CN CNA031264069A patent/CN1515559A/zh active Pending
- 1998-06-22 CN CNB981152090A patent/CN1176910C/zh not_active Expired - Fee Related
- 1998-06-22 CZ CZ981974A patent/CZ197498A3/cs unknown
- 1998-06-22 PL PL326959A patent/PL198053B1/pl not_active IP Right Cessation
- 1998-06-22 AU AU73102/98A patent/AU713068C/en not_active Ceased
- 1998-06-23 TR TR1998/01197A patent/TR199801197A2/tr unknown
- 1998-06-23 BR BRPI9802201-6A patent/BR9802201B1/pt not_active IP Right Cessation
- 1998-06-23 HR HR60/075,978A patent/HRP980353A2/hr not_active Application Discontinuation
- 1998-06-23 TW TW087110098A patent/TW517049B/zh not_active IP Right Cessation
-
1999
- 1999-03-08 US US09/264,467 patent/US6057349A/en not_active Expired - Fee Related
- 1999-05-24 HK HK99102263A patent/HK1016985A1/xx not_active IP Right Cessation
-
2003
- 2003-09-04 IL IL15774503A patent/IL157745A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID20463A (id) | Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea | |
ID23575A (id) | Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina | |
ID28114A (id) | Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait | |
ID19824A (id) | Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya | |
ID19422A (id) | Piridina dan bifenil tersubstitusi | |
ID24476A (id) | Arilsulfonamida dan analognya | |
ID22957A (id) | Senyawa dan penggunaannya | |
ID29591A (id) | Senyawa-senyawa kuinolina dan kuinoksalina | |
ID24839A (id) | Senyawa-senyawa triazol dan penggunaannya | |
ID24148A (id) | Turunan-turunan fitostfrol dan/atau fitostanol | |
ID23684A (id) | Komposisi-polimer-organoclay dan pembuatannya | |
ID19833A (id) | Aralkil dan aralkilidena heterosiklik laktam dan imida | |
ID21361A (id) | Baterai dan metode pembuatannya | |
ID22708A (id) | Perangkai gen dan metodanya | |
ID22223A (id) | Turunan-turunan sulfonil urea dan penggunaanya dalam pengendalian aktivitas interleukin-1 | |
ID26599A (id) | Turunan triazola dan imidazola | |
ID16570A (id) | Pembuatan amina-amina dan aminonitril-aminonitril | |
ID24196A (id) | Komposisi dan penggunaan | |
ID20902A (id) | Proses produksi kombinasi amonia dan urea | |
ID24844A (id) | Metode dan sistem selimut aplikasi | |
ID16889A (id) | Senyawa turunan alkilaminobenzotiazol dan benzoksazol | |
ID18456A (id) | Produksi-bersama 6-aminokapronitril dan heksametilenadiamina | |
ID24872A (id) | Komposisi pengawet berdasarkan senyawa donor formaldehide dan iodopropinil | |
ID29052A (id) | Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina | |
ID21382A (id) | Katalis polimerisasi dan proses-prosesnya |